Vaccine development against malaria.


Malaria vaccine development aims to significantly reduce mortality and morbidity in the two high-risk groups: young children and pregnant women in sub-Saharan Africa. A pre-erythrocytic subunit vaccine, RTS,S, was recently evaluated in a first Phase IIb clinical trial in young children that live in a mesoendemic area of malaria transmission. The… (More)


Cite this paper

@article{Matuschewski2006VaccineDA, title={Vaccine development against malaria.}, author={Kai Matuschewski}, journal={Current opinion in immunology}, year={2006}, volume={18 4}, pages={449-57} }